Regenerative Hepatology Consortium Symposium Program June 2024

3^rd International Symposium on Regenerative Hepatology

Organized by: EASL Regenerative Hepatology Consortium

June 4, 2024 9:00-17:30

Venue:

CASA CARDINALE ILDEFONSO SCHUSTER

Via Sant’Antonio, 5 – 20122

Milan, Italy

Opening

9:00-9:10 – Welcome and opening of the symposium by Pedro Baptista, Etienne Sokal, Tobias Cantz and Bart Spee.

Gene Therapy/Editing and other Novel Therapies in Regenerative Hepatology

9:10-9:40 – The development of novel therapies for Amyloidosis, Vittorio Bellotti, IRCCS Policlinico San Matteo, Pavia, Italy

9:40-10:10 – Prime time for gene-correction therapies targeting the liver, Sabine Fuchs, Utrecht University, Utrecht, The Netherlands

10:10-10:40 – Curing Crigler-Najar with Gene Therapy, Lorenzo D’Antiga, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

10:40-11:00 – Discussion

11:00-11:30 Coffee break

AI, Modeling and Simulation: The New Frontiers in Regenerative Hepatology

11:30-12:00 – Modeling liver regeneration and bile duct development in silico, Paul van Liedekerke, Ghent University, Ghent, Belgium

12:00-12:30 – AI liver allocation algorithms in liver transplantation, Patricia Burra, University of Padova, Padova, Italy

12:30-13:00 – 3D spatially-resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression, Prof. Marino Zerial, Human Technopole, Milan, Italy

13:00-14:00 Lunch Break

Industry Session: Uncovering new products with potential in Regenerative Hepatology

14:00-14:10 – Miltenyi Biotec

14:10-14:20 – BeCytes Biotechnologies SL

14:20-14:30 – Optimised iPSC-derived hepatocytes (Opti-HEP) as a novel in vitro platform in drug efficacy and toxicity screening, Nikolaos Nikolaou, DefiniGEN Ltd.

14:30-14:40 – Cellaïon

14:40-14:50 – Apersys AG

Poster session

15:00-16:00 – Rapid fire poster presentations (5 minutes for each presenter)

Regenerating Livers Left and Right: Bioengineering and Cell Therapies for the Liver

16:00 Bioengineering liver models for in vitro applications, Volker Lauschke, Karolinska Institute, Sweden

16:30 Bioengineering approaches for drug discovery, Alan Holmes, Engitix Therapeutics Ltd, London, UK.

17:00 M2 Macrophages cell therapy in chronic liver disease, Stuart Forbes, Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh, UK

17:30 Closure

___________________________________________________________________________

Abstract Submission

Abstract submission will be open from March 25^th until May 25^th.

Please submit your abstracts at: mail@regenerativehepatology.com

We will award a 1^st prize of 150 EUR to the best poster.

Coffee breaks and lunch will be provided.

Registration

Please register at mail@regenerativehepatology.com before May 25, 2024.

REGISTRATION FEE: 75 EUR

Should be paid at:

Foundation for Regenerative Hepatology